Updated clinical recommendations for the use of tibolone in Asian women

Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction

(2009) E. A. Nijland et al.   CLIMACTERIC

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

(2009) Peter Kenemans et al.   LANCET ONCOLOGY

In reply:

(2009) Wulf H. Utian   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Effects of race and ethnicity on the incidence of venous thromboembolism

(2009) Richard H. White et al.   THROMBOSIS RESEARCH

Hormone therapy and risk of myocardial infarction: a national register study

(2008) E. Lokkegaard et al.   EUROPEAN HEART JOURNAL

FSD PHARMACOTHERAPY: Tibolone and Transdermal E2/NETA for the Treatment of Female Sexual Dysfunction in Naturally Menopausal Women: Results of a Randomized Active-Controlled Trial

(2008) Esme A. Nijland et al.   Journal of Sexual Medicine

Hormone replacement therapy use and the risk of stroke

(2008) Christel Renoux et al.   MATURITAS

The Effects of Tibolone in Older Postmenopausal Women

(2008) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women

(2008) P. D. Delmas et al.   OSTEOPOROSIS INTERNATIONAL

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL